High Bridge, NJ, United States of America

Ann T Woods

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Roussel Pharmaceuticals. Active years: 1994.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ann T Woods - Innovator in Pharmaceutical Treatments

Introduction

Ann T Woods is a notable inventor based in High Bridge, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of obsessive-compulsive disorders. Her innovative approach has led to the development of a unique method that utilizes specific compounds for therapeutic purposes.

Latest Patents

Ann T Woods holds 1 patent for her work titled "Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorders." This patent discloses a method of alleviating these disorders through the administration of an effective amount of a compound of a specific formula. Her research has the potential to improve the lives of many individuals suffering from this condition.

Career Highlights

Throughout her career, Ann has been associated with Hoechst Roussel Pharmaceuticals, where she has applied her expertise in pharmaceutical development. Her work has been instrumental in advancing treatment options for mental health disorders, showcasing her dedication to improving patient outcomes.

Collaborations

Ann has collaborated with esteemed colleagues such as Sathapana Kongsamut and Craig P Smith. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.

Conclusion

Ann T Woods is a pioneering inventor whose work in the pharmaceutical industry has made a significant impact on the treatment of obsessive-compulsive disorders. Her contributions continue to inspire advancements in mental health therapies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…